Journal of Pharmacy and Pharmacology · 1994 · 115 citations · 12 references
MedicinePharmacokineticsPharmacologyBiochemical PharmacologyImmunopharmacologyMolecular PharmacologyDrug DispositionPharmacokinetics Across SpeciesPlasma ProteinsProtein BindingIntracellular Drug ConcentrationMolecular Weight DeterminationPharmacokinetics Of Immunosuppressive AgentsProtein Pharmacokinetics
The distribution of FK506 in the blood was estimated in-vitro. At a drug level of 5 ng mL-1, FK506 mainly distributed in erythrocytes (95-98%) in dog, monkey and human blood, and its distribution was affected by drug concentration, temperature, and haematocrit values. In erythrocytes most of FK506 was distributed in cytoplasmic components and was bound strongly to a protein having a molecular weight of 10-11 kDa. The molecular weight of this protein agrees with FK506-binding protein found in various cells. Greater than 98.8% of FK506 was bound to the plasma proteins in all species studied. FK506 bound to various plasma proteins such as lipoproteins, globulins, alpha 1-acid glycoprotein and albumin.
12
A highly sensitive method to assay FK-506 levels in plasma.
Kyoichi Tamura, Minoru Kobayashi, Kazuhiko Hashimoto et al. · PubMed · 1987 · 148 citations
John J. Siekierka, Mary Jo Staruch, Shih‐Han Hung et al. · The Journal of Immunology · 1989 · 140 citations · Full text
John J. Siekierka, Greg Wiederrecht, Heidi Greulich et al. · Journal of Biological Chemistry · 1990 · 133 citations · Full text